Table of Contents
Preface
Chapter 1. Fragility Fractures: Risk Factors and Management Strategies
Ilias D. Iliopoulos1, MD, Angelos Kaspiris2, MD, Argyris C. Hadjimichael3, MD, PhD, Ioanna Lianou1, MD, Dimitra Melissaridou4, MD, Olga D. Savvidou4, MD, PhD and Efstathios Chronopoulos5, MD, PhD
1Department of Orthopaedic Surgery, “Rion” University Hospital and Medical School, School of Health Sciences, University of Patras, Patras, Greece
2Laboratory of Molecular Pharmacology, Group for Orthopaedic Research, School of Health Sciences, University of Patras, Patras, Greece
3Department of Orthopaedics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK
4First Department of Orthopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, “ATTIKON” University General Hospital, Athens, Greece
5Laboratory for Research of the Musculoskeletal System, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Chapter 2. Cognitive Reserve in Substance Addiction: Potential Biomarkers for Future Research
Nerea Requena-Ocaña1,2,3, M. Carmen Mañas-Padilla1,4, Fernando Rodríguez de Fonseca1,3, Linda Montanari5, Patricia Sampedro-Piquero6, Estela Castilla-Ortega1,4 and Pedro Araos1,4
1Biomedical Research Institute of Malaga and Nanomedicine Platform-IBIMA BIONAND Platform, Spain
2School of Psychology, Complutense University of Madrid, Campus de Somosaguas, Madrid, Spain
3Mental Health Clinical Management Unit, Hospital Regional Universitario de Málaga
4Department of Psychobiology and Methodology of Behavioral Sciences, University of Malaga
5Prevalence, Consequences and Data Management Unit, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal
6Department of Biological and Health Psychology, Autonomous University of Madrid, Cantoblanco, Madrid, Spain
Chapter 3. An Overview of the Fracture Healing Process and Risk Factors for Non-Unions
Argyris C. Hadjimichael1, MD, MSc, PhD, Angelos Kaspiris2, MD, MSc, PhD, Jim D. Georgoulis3, MD, Athanasios F. Foukas4, MD, Ilias D. Iliopoulos5, MD, Ioanna Lianou5, MD, Dimitra Melissaridou3, MD, Olga D. Savvidou3, MD, PhD and Efstathios Chronopoulos6, MD, PhD
1Department of Orthopaedics, Dikteon Medical Center, Nicosia, Cyprus
2Laboratory of Molecular Pharmacology, Department of Pharmacy, School of Health Sciences, University of Patras, Greece
3First Department of Orthopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, “ATTIKON” University General Hospital, Rimini, Athens, Greece
4Third Department of Orthopaedic surgery, “KAT” General Hospital of Athens, Kifissia, Greece
5Department of Orthopaedic Surgery, “Rion” University Hospital and Medical School, School of Health Sciences, University of Patras, Patras, Greece
6Laboratory for Research of the Musculoskeletal System, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Chapter 4. Virtual Screening in a Dataset of FDA-Approved Drugs to Discover NLRP3 Inflammasome Inhibitor Promising against Inflammatory Diseases
Yvnni Maria Sales de Medeiros e Silva1,2, MS, Daniel Calazans Medeiros2, BHSc, Marianny de Souza2, BHSc, Ricardo Olimpio de Moura1,2, PhD and Igor José dos Santos Nascimento1,2,3,, PhD
1Programa de Pós-Graduação em Ciências Farmacêuticas, Universidade Estadual da Paraíba, Campina Grande, PB, Brazil
2Laboratório de Desenvolvimento e Síntese de Fármacos, Departamento de Farmácia, Universidade Estadual da Paraíba, Campina Grande, Brasil
3Pharmacy Department, Cesmac University Center, Maceió, Alagoas, Brazil
Chapter 5. Atypical Femoral Fractures After the Administration of Bisphosphonates and Denosumab for the Treatment of Osteoporosis
Angelos Kaspiris1, MD, MSc, PhD, Ioanna Lianou, MD2, Ilias D. Iliopoulos2, MD, Argyris C. Hadjimichael3, MD, MSc, PhD, Dimitra Melissaridi4, MD, Olga D Savvidou4, MD, PhD and Efstathios Chronopoulos5, MD, PhD
1Group of Orthopaedic Research, Laboratory of Molecular Pharmacology, Department of Pharmacy, School of Health Sciences, University of Patras, Patras, Greece
2Department of Orthopaedic Surgery, “Rion” University Hospital and Medical School, School of Health Sciences, University of Patras, Patras, Greece
3Department of Orthopaedics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, UK
4First Department of Orthopaedic Surgery, School of Medicine, National and Kapodistrian University of Athens, “ATTIKON” University General Hospital, Athens, Greece
5Laboratory for Research of the Musculoskeletal System, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
Chapter 6. Health Damage Caused by the Metabolite Cotinine
Daiana Dalberto1,2, Ana Letícia Hilário Garcia1,2, Fernanda Rabaioli da Silva1,2 and Juliana da Silva1,2
1Laboratory of Genetic Toxicology, La Salle University (UniLaSalle), Canoas, Rio Grande do Sul, Brazil
2Laboratory of Genetic Toxicology, PPGBioSaúde, Lutheran University of Brazil (ULBRA), Canoas, Rio Grande do Sul, Brazil
Chapter 7. Warts as Accumulators of Viral Nucleotides for Chromosomes: Diagnostics of Virus Genomes in Vivo
Kristina Zubow1, Anatolij Zubow2 and Viktor Zubow1
1R&D, Zubow Consulting (NPO), Peenehagen, Germany
2Dept. Telecommunication Networks Group, Berlin, Germany
Chapter 8. Throat Carriage Rate, Associated Factors, and Antimicrobial Susceptibility Patterns of Group A Streptococcus among Healthy School Children in Jigjiga City, Eastern Ethiopia
Shamil Barsenga1, Habtamu Mitiku2, Tewodros Tesfa2 and Tadesse Shume2
1Jigjiga University, College of Medicine and Health Sciences, Department of Medical Laboratory Sciences, Jigjiga, Ethiopia
2Haramaya University, College of Health and Medicine Sciences, School of Medical Laboratory Sciences, department of Medical Microbiology and Immunology, Harar, Ethiopia
Index
